Publications Repository 2016

Aapro, M et al (2016) Predictive modeling of the outcomes of chemotherapy induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (MONITOR-GCSF study). Annals of Oncology 27: 2039–2045
Dhatariya, K et al (2016) An open, non-comparative, multicentre evaluation of performance and safety using an antimicrobial exudate transfer dressing on diabetic foot ulcers: a case series. Journal of Wound Care 25:5, 256-265
Fortnum, Heather (2016). The diagnostic accuracy of hearing tests and cost effectiveness of school-entry hearing screening programmes. Published in: Fortnum H et al. A programme of studies including assessment of diagnostic accuracy of school hearing screening tests and a cost-effectiveness model of school entry hearing screening programmes. Health Technol Assess May; 20 (36)
Gascón, Pere (2016) Treatment patterns and outcomes in the prophylaxis of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim (the MONITOR-GCSF study). Supportive Care in Cancer 24:911–925
Gascón, Pere (2016) Erratum to: Treatment patterns and outcomes in the prophylaxis of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim (the MONITOR-GCSF study). Supportive Care in Cancer 24:927
International Surgical Outcomes Study Group (2016). Global patient outcomes after elective surgery: prospective cohort study in 27 low-, middle- and high-income countries. British Journal of Anaesthesia 117 (5): 601-609.
Jackson, Andrew (2016) Vascular access passports. British Journal of Nursing 2016 25:19, S34-S34
Mowat, C et al (2016) Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial. The Lancet Gastroenterology & Hepatology Volume 1, No. 4, p273–282
Turton, Tracey (2016) Tuberculosis Nursing Service Review: The TB Nursing Service – Patient Satisfaction Questionnaire Results and Evaluation. Rotherham NHS Foundation Trust.
Williams, John G et al (2016) Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial. The Lancet Gastroenterology & Hepatology, Volume 1 , Issue 1 , 15 - 24.